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Abstract: 
The tenth conference of the AfSHG was held in Egypt with the theme “Human 
Genetics & Genomics in Africa: Challenges for both Rare & Common Genetic 
disorders”. Current research was presented and we discussed visions for the future of 
genomic research on the African continent. In this report we summarize the presented 
scientific research within and relevant to Africa as presented by both African and non-
African scientists. We also discuss the current situation concerning genomic medicine 
and genomic research within the continent, difficulties in implementing genetic 
services and genomic medicine in Africa and a roadmap to overcome those difficulties 
and meet the needs of the African researchers and patients.  
Introduction 
The African Society of Human Genetics (AfSHG), launched in 2003, aims to propose 
strategies for the translation of genomic knowledge to address the public health burden 
of diseases across the continent, and to develop a roadmap for increasing and spreading 
this knowledge within and beyond the continent1. The AfSHG proposed new 
strategies2,3 to provide assistance to countries with the highest burden of genetic 
disorders and ensure that Africa is not left behind in a “genomic divide”. As a result, 
several funding bodies have invested in genomic research that has contributed to 
building research capacity in Africa. A key instrument of this investment has been the 
Human Heredity and Health in African Consortium (H3Africa), a Pan-African research 
consortium focusing on human health-related genomics and genetics research on the 
continent, funded largely by the National Institutes of Health in the USA and the 
Wellcome in the UK. This initiative was first discussed as a possibility ten years ago at 
the 2007 AfSHG meeting in Cairo.  H3Africa fostered the beginnings of large-scale 
implementation of genomic technologies aimed at improving the health of Africans 
[http://h3africa.org] during a first phase (2012 to 2017) that included eight collaborative 
centers, seven research projects, six ethics projects, three H3Africa biorepository sites 
and a Pan-African bioinformatics network with 26 research groups in 27 African 
countries4-9. Enhanced research capacity requires appropriate planning and 
funding to develop thriving and sustainable networks throughout the continent.  
In line with these goals3–8, 10,11, the tenth conference of the AfSHG was held in 
partnership with the National Society of Human Genetics in Egypt (NSHG-Egypt) 
and the H3Africa Consortium in Cairo from November 16-18, 2017.  Four hundred 
and fifty-three scientists from 32 countries attended the meeting [Figure]. To 
encourage attendance by investigators and trainees with limited resources, 72 travel 
fellowships to junior and senior African researchers were granted. In an attempt to 
ensure unity across the African continent, simultaneous translation into French was 
provided. Webcasting of many of the conference’s sessions were available to allow 
broader participation [http://www.nshg-society.eg.net/activities.html]. 
Satellite events: 
Young Researchers Forum  
A Young Researchers’ Forum (YRF) was held the day before the main meeting so that 
young researchers could present their research and exchange experiences. There were 
16 oral and 33 posters and presenters interacted with their peers and senior researchers. 
The theme was “Hand in Hand to Change the Genetic Research Future over the 
African Land”. Presented scientific research topics included common traits with 
genetic susceptibility, genetic diagnostics, and cancer and six young researchers were 
awarded special prizes, three to the best oral and three to the best poster presenters in 
the form of travel grants for the next AfSHG conference.  Other awardees received 
books.  An important outcome of these YRFs at the AfSHG meetings is the 
development of formal and informal networks to enhance relationships, and develop 
future partnerships amongst emerging researchers. 
Educational Initiative 
An ‘early bird’ workshop on Next Generation Sequencing (NGS) was run by Prof. 
Samar Kassim and Dr. Amadou Gaye over three mornings that covered the basics of 
NGS library preparation, data processing pipeline, quality control, and provided 
exemplars of single-variant and gene-based analyses. This session was instrumental in 
exposing African researchers to the latest genomic technologies, data analyses, and 
their uses.  
Scientific highlights from the main conference  
The official opening of the conference included introductions by Michèle Ramsay 
(University of the Witwatersrand, South Africa), the president of the AfSHG, Samia 
Temtamy, president of the Egyptian National Society of Human Genetics, and 
Ambroise Wonkam (University of Cape Town, South Africa) from the steering 
committee of H3Africa. In addition, the Egyptian Assistant Foreign Minister for 
African Affairs (Mohamed Idris), the vice president of National Research Centre-Egypt 
(NRC) (Mohamed Hashem) and the President of the Academy of Scientific Research 
and Technology-Egypt (ASRT) (Mahmoud Sakr) addressed the meeting.   
The meeting began with an appraisal of African Genomic Research discussing the 
future impact of genetic diversity and African genomic data on understanding and 
improving the efficacy and safety of therapeutic drugs on the path to attaining 
individualized medicine (precision medicine). In light of many of these issues, the first 
plenary talk at the conference by Charles Rotimi, the founding president of the AfSHG 
and Head of the Center for Research on Genomics and Global Health (National 
Genome Research Institute, USA), addressed the impact of Africa’s genetic diversity 
in the dawn of precision medicine. In his presentation, he challenged African scientists 
with a new dream to develop a 5-million Pan-African population cohort, one million 
from each African region, as a resource for studying disease prevalence and causality, 
and to provide a framework for human genetics on the continent. The information from 
such a cohort would propel research into precision medicine within Africa and beyond.  
Next, Yehia Gad (National Research Center, Egypt), a senior medical geneticist, 
brought a unique Egyptian flavor to the meeting with a presentation on genomic 
research to elucidate the identity of a number of suspected royal Egyptian mummies, 
investigating their family relationships to historically identified mummies and making 
use of genetic kingship analysis. Providing insight into the state of medical genetics 
and diagnostics in Africa, Prosper Lukusa, President of the Congolese Society for 
Human Genetics (CoSHG), discussed hardships in establishing genetic testing in 
Democratic Republic of Congo the dire need for support. He proposed sharing existing 
resources with other African and/or European laboratories. Rokhaya Ndiaye (Sheikh 
Anta Diop University, Dakar, Senegal) reported on a pilot project to investigate the 
incidence of congenital malformations in Dakar. Researchers from Cameroon and 
Egypt discussed their initial results from next generation sequencing (NGS) of gene 
panels and whole exome analyses that potentially led to the identification of the causal 
mutations for genetic disorders. The H3Africa Consortium announced the design of a 
~2.3-million SNV genotyping array as an African-centric, unbiased and cost effective 
solution for genome-wide analysis for complex traits and population genetics research 
on the continent.  
A session on “Stem cells in medical genetics” discussed the capability of dental pulp 
stem cells (DPSCs) to promote peripheral and central nerve regeneration as well as 
vasculogenesis/angiogenesis in ischemic hind limb (Misako Nakashima, Nagoya 
University, Japan and Shin Kwamata, Foundation for Biomedical Research and 
Innovation (FBRI) Center for Cell Therapy, Japan). Secretome-based therapy for 
Alzheimer's disease was presented (Misako Nakashima).  Stem cell research targeting 
diabetes therapy with regard to potential deriving functional human pancreatic β cells in 
vitro and β cell transplantation therapy in disease modeling was also presented (Reham 
Aly, National Research Centre, Egypt). 
The Egyptian maxillo-facial dental genetics team reported on combining stem cell 
therapy with autogenous growth factors in treatments involving bone, soft tissue, fat 
and muscle regeneration for different clinical cases that resulted in extraordinary 
recovery (Ahmad Farouk, National Research Centre, Egypt and Nermeen Ahmad, 
National Research Centre, Egypt). Another Egyptian study reported stem cells obtained 
from periodontal ligament as a promising treatment modality for regenerating tissues 
destroyed by the periodontal diseases (Maha Abdelfattah, National Research Centre, 
Egypt). 
Talks in the session on Cancer Genetics and Genomics included new methods 
for screening for high-risk human papilloma virus strains by testing for the E6/E7 
oncoprotein reported in Rwanda (Leon Mutesa, University of Rwanda). Scott Williams 
(Case Western Reserve University, USA) spoke about cancer and co-evolution with 
Helicobacter pylori concluding that the interaction between the host and pathogens, in 
terms of ancestry, could account for a large proportion of the difference in disease risk 
previously associated with geography. In particular, African H. pylori ancestry that was 
relatively benign in people of African descent was shown to be deleterious in 
individuals with substantial Native American ancestry. Collaborative work in 
epidemiological genetic studies and clinical genomics, with the aim of primary 
prevention and early detection programs of cancer, were discussed while reporting an 
increased incidence of cancer, particularly hepatocellular carcinoma in Africa (Abdel 
Hady). There were also studies pointing to a central role of the Fanconi anemia (FANC) 
pathway in cellular and chromosomal resistance to DNA damage in melanoma cells 
(Filippo Rosselli, Gustave-Roussy Institute, Paris, France). 
Genomic variation was explored, specifically with regard to African-descent 
population genetic diversity and its impact on health and the variable distribution of 
different disorders throughout the sessions on cancer, other common non-
communicable genetic disorders and infectious diseases. There was an emphasis on 
gene-environment interactions and their impact on the distribution of common and 
complex diseases in Africa (Ayo Doumatey, National Human Genome Research 
Institute (NHGRI, USA) and Raj Ramesar, University of Cape Town, South Africa). 
In the field of genetics of rare disorders and epidemiology, a study on 
genodermatoses in Egypt presented an example of increased incidence of disorders in 
African countries where consanguineous marriages are common (Ghada El Kamah, 
National Research Centre, Egypt and Mohamed Abdelkader, National Research Centre, 
Egypt). Whole exome sequencing in consanguineous families with genetic disorders 
was reported as an effective tool for novel disease gene discovery and for the detection 
of novel mutations in previously identified genes causing disease in patients from 
Tunisia, Egypt and Mali (Sonia Abdelhak (Research Laboratory on `biomedical 
Genomics and Oncogenetics, Istitut Pasteur, Tunisa), Inas Mazen (National Research 
Centre, Egypt) and Guida Landoure (Faculté de Médecine et d’Odontostomatologie, 
USTTB and Service de Neurologie, Centre Hospitalier Universitaire du Point G, Mali). 
The clinical and molecular landscape of neurogenetics, including brain 
malformations, microcephaly and intracranial calcifications, were presented (Ghada 
Abdel-Salam, National Research Centre, Egypt and Maha Zaki, National Research 
Centre, Egypt) together with some solutions such as 3D surgery in the treatment of 
unicoronal craniosynostosis (Tarek Elbanouby, Al-Azhar University, Egypt). An 
H3Africa study reported an initiative to discover causative genes for neurogenetic 
disorders in African communities with high fertility and consanguinity rates. Revising 
the content of gene panels to avoid erroneous conclusions in African populations, was 
an important recommendation from the meeting. This followed reports on studies 
showing that NGS combined with linkage analysis, whole exome sequencing and 
whole genome sequencing facilitated novel disease gene discovery (Faisal Fadlelmola, 
University of Khartoum, Sudan). Kenneth Fischbeck (National Institute of 
Neurological Disorders and Stroke, USA) presented studies of neurological diseases 
and provided perspectives on treatment, some of which are already in the market or in 
Phase III clinical trials. 
During the session on NGS approaches and bioinformatics training, there were 
presentations on big data and genomics, variability in allele frequencies, linkage 
disequilibrium, genome-wide association studies (Hanno Boltz, University Hospital of 
Cologne, Germany), current and prospective use of bioinformatics to serve genetics and 
genomic research in Africa. Benefits, challenges and pitfalls of decoding inherited 
diseases in consanguineous families in the era of high-throughput DNA sequencing 
were discussed. H3Africa’s bioinformatics network, H3ABioNet 
[https://h3abionet.org/], which has representation across countries from Cape Town, 
South Africa to Cairo, Egypt, described the use of webinars as a model for providing a 
forum for consortium members working in bioinformatics and computational genomics 
as well as their application to various aspects of genomic medicine (Samar Kassim, Ain 
Shams University, Egypt).  
Hans Hagen (Institute Pasteur, Paris) discussed the Pan-African Coalition for 
Training in Research and Public Health (PACT) that aims to provide collaborative and 
disciplinary platforms for training in both trusted and novel technologies across a range 
of disease domains, and the creation of a network allowing the sharing of skills and 
resources.  
In the domain of translational genomics in African research, pharmacogenetics 
and diagnostic applications of genomic research in Africa were thoroughly discussed 
(Collen Masimirembwa, African Institute of Biomedical Science and Technology, 
Zimbabwe). The use of international collaborative databases with consideration of 
different ethnic backgrounds, allows the comparison of individuals suffering from a 
variety of genetic syndromes. This included reporting of both subjective clinical 
findings and objective facial recognition technology differences detected between 
various populations for selected syndromes (Maximilian Muenke, National Human 
Genome Research Institute, USA).  
Obesity as one of the common traits with a genetic susceptibility and a 
contemporary health burden was discussed in light of concerns about the effect of 
obesity on transcriptomic changes and the use of multiple molecular tools to identify 
molecular changes associated with obesity and obesity related traits; functionally these 
can include epigenetic modifications, including miRNA regulation. Array comparative 
genomic hybridization (CGH) was presented as a tool for genetic analysis of changes 
in schizophrenic patients. 
Hereditary disorders of the blood impose an important health burden in Africa, 
especially sickle cell anemia and the diagnosis of congenital hemolytic anemia. In the 
NGS era, a panel covering 26 genes was developed to address the problem of 
genetically heterogeneous undiagnosed congenital hemolytic anemia (Ambroise 
Wonkam, Celeste Bento). Mutagenesis in adaptive immunity addressed the genetic and 
biochemical mechanisms that showed that somatic hypermutations are diverted from 
their normal functions, being used in rather atypical ways in order to favor mutagenesis 
over accuracy (Said Aoufouchi, Gustave Roussy Cancer Center, France). Another study 
concerned with the analysis of DNA-protein cross-link damage induced by genotoxic 
agents concluded how living organisms cope with the threat from genotoxic agents and 
maintain their global genetic integrity (Amir Salem, National Research Centre, Egypt). 
 
Non-coding RNAs, as new diagnostic markers, were presented as promising 
biomarkers that will be able to predict and enable early diagnosis of hepatocellular 
carcinoma patients (Olfat Shaker, Cairo University, Egypt). Studies on how severe 
dysfunction of the immune system affects the clinical presentation of inborn errors of 
immunity and human diseases, how they are currently studied as a model to decipher 
immune mechanisms involved in the emergence of other associated clinical 
manifestations including allergy, auto-immunity and malignant lymphoproliferation, 
and how their genetic basis is shaping the understanding of those more complex 
multiple issues were discussed (Ridha Barbouche, University of Tunis, Tunisia).  
 
The last session reported on establishing a Center of Excellence for Human Genetics in 
Egypt. Five clinical researchers highlighted the value and complementarity of 
coordinating different genetics subspecialties to better serve patients with genetic 
disorders and promote research (Khalda Amr, Mona Aglan, Mona Essawy, Naglaa 
Kholousy, and Khaled Gaber, all of  National Research Centre, Egypt).  
Among important topics discussed affecting scientific research in an African setting 
were ethics and biobanking (Paul Ndebele, Medical Research Council of Zimbabwe), 
where the ethical sufficiency of informed consent for justifying research has been 
important for the development of research resources. Challenges involving 
implementation and sustainability of African biobanks were discussed, stressing the 
quality of informed consent, particularly where possible future use of biological 
material is concerned. Participants from Nigeria, Uganda and Zimbabwe presented 
their experiences with biobanking. Under the umbrella of the H3Africa Consortium, 
there were discussions on the setup of well-coordinated, high quality biorepositories as 
well as the framework for evaluating the ethical soundness of genomic research and 
biobanking by ethics review boards across the African continent. What was evident was 
the shift in thinking with regards to ‘genomic sovereignty and exceptionalism’ to 
recognizing the true value of sharing data and biological material – if there is any hope 
of the benefits of research being brought back to source research populations. However, 
what was also clear is that there are very different levels of engagement between 
funders and collaborators on the international stage leading to the need for a complex 
series of discussions for engagement between researchers, communities and 
governments (Ananyo Choudhury (University of the Witwatersrand), James Onyemata 
(institute of Human Virology, South Africa) and Bazondile Dube-Marimbe (University 
of Zimbabwe)). 
There was a parallel workshop affiliated to The Human Variome Project concerned 
with hemoglobinopathies as a health problem on the continent and the impact of 
genomic data sharing on research (Zilfalil Bin Alwi (Hospital University Sains, 
Malaysia), Raj Ramesar (University of Cape Town) and NarazahYusoff (Hospital 
University Sains, Malaysia).  
 
Strategic planning for the future 
The meeting planned to amplify research activities, enhance resources in Africa and 
leverage synergies between the AfSHG, H3Africa and other relevant initiatives as well 
as better engaging African citizens in genomics. A key question is, how the AfSHG can 
benefit those working on African genetics and achieve a sustainability model with a 
more diverse and stable funding. The following suggestions emanated from the 
meeting: (i) Live webinars to discuss common genetic issues; (ii) Mentor junior 
researchers to organize the discussion; (iii) Strengthen partnerships; (iv) Organize 
future conferences in conjunction with relevant meetings for cross-fertilization of 
research across disciplines.  
Main conclusions from the conference  
There is an urgent need to leverage synergies and develop guidelines to achieve specific 
goals. We need to expand our efforts to close the genomic gap between Africa and 
other regions. The field of genetics is a rapidly expanding global initiative and 
advancing genetics and technological knowledge in Africa depends on Pan-African 
as well as African-international cooperative arrangements between professionals. 
An excellent strategy would be to reinforce existing genetics centers that have a 
critical mass of trained people. The AfSHG is at a point where it needs to think 
carefully about the future and to understand what young scientists want from 
their society and how to fulfill their dreams and support their scientific ambitions 
in the years to come. A lack of local opportunities leads to Africa’s loss of some 
20,000 professionals to high-income countries every year [10]. To move forward it 
is essential to examine existing capacities, for instance through building human 
genetics centers (HGC) and research networks and/or hubs across the continent. 
This can be achieved through the development of: (I) clinical phenotyping centers, 
(II) molecular phenotyping centers, (III) genotyping and sequencing capability, 
(IV) data centers, and (V) sustainable biorepositories in Africa3. Genetic diagnosis 
and application of genetic testing for rare and common genetic disorders should 
be the basis for future development. There is also a need to support training 
programs for clinical genetics, laboratory genetic testing and genomics research. 
Seeking international support is mandatory for bridging the gaps in financial as 
well as technological resources in medical genetics practice in Africa in order to 
fulfill both recommendations. Another way to develop knowledge in genetics and 
genomic science through the existing networks is to work toward establishing an 
African School of Human Genetics. 
The AfSHG presented ideas for a roadmap and a vision for sustaining and spreading 
genomic knowledge in Africa. African initiatives need acknowledgment of Human 
Genetics as significant to public health. The International Monetary Fund (IMF) 
predicts Africa as the world’s second-fastest growing economy by 202010-12 and trained, 
competitive, scientists are essential to accelerate the acquisition of knowledge and 
development across the continent. Skilled workforces can attract private-sector 
investment and sustainability needs funding from Africa itself rather than relying only 
on foreign investors. It is difficult to define the scale of the challenges ahead, but there 
are clear and exciting opportunities for genetics and genomics on the continent.  
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Figure: Participant countries at the 10th AfSHG meeting, Cairo, 2017 
  
 
 
 
 
 
